Release Announcement
- Release Announcement – Signals Clinical 2.3
- Release Announcement - Signals Deferred Release version Validation 24.7.5 update to Staging Environments
- Release Announcement - Signals Update, 24.8.3
- Release Announcement - Signals Update, 24.8.2
- Release Announcement - Signals Update, 24.8.1
- Release Announcement - Signals Research Suite, Including Signals Notebook Update, 24.8
Sunset Notice
- Sunset Notice – ChemBioOffice Enterprise (CBOE) versions 19.x, 20.x and 21.x
- Sunset Notice – E-Notebook Enterprise versions 19.x, 20.x and 21.x
- ChemDraw Perpetual Licenses will be discontinued on January 1st, 2025
- End of Life Notice – Lead Discovery
- Sunset Notice: Signal Notebook Individual Edition
- Sunset Notice: ChemOffice
Security Alert
- Security Advisory for TIBCO Products
- Windows Server updates released on November 8, 2022 or later may cause Sign in failures and other issues related to Kerberos authentication.
- Security Advisory for TIBCO Products
- Resolution and Mitigation for the Apache Commons Text (Text4Shell) Vulnerability
- Security Advisory for TIBCO Products
- Java Spring Framework Vulnerability
General News
- Product Basics - A new learning resource now available
- Reminder regarding whitelisting IP addresses for Proxy service
- Signals VitroVivo and Inventa: Compatibility Alert Update
- Signals VitroVivo: Important Compatibility Alert
- Signals Inventa: Important Compatibility Alert
- Changes to image editing in Text Editor
Server Outages
- 2024 AUG 26 Signals Notebook and Signals Research Suite Outage - RESOLVED
- Signals Notebook and Signals Research Suite Outage - UPDATE
- Signals Notebook and Signals Research Suite Outage
- Signals Notebook and Signals Research Suite Outage - UPDATE
- Planned Outage: Spotfire Personal Subscription Server
- Licensing and Authentication Planned Maintenance